Holopack Selects SAP and Answerthink's EzPharma Solution to Streamline Business Processes and Position for Growth
May 15 2007 - 9:30AM
Business Wire
Answerthink, Inc. (NASDAQ: ANSR), announced today that Holopack
International has selected EzPharma, an SAP� All-in-One solution
from Answerthink that is preconfigured with best practices and
functionality specifically for growing pharmaceutical delivery and
manufacturing companies. Holopack is a leading innovator of liquid
pharmaceutical delivery systems headquartered in Columbia, SC. The
company�s liquid dose drug delivery systems allow for quick,
portable, and sterile delivery of medications and other products.
Holopack�s vision was to select and install a �user friendly�
solution that would allow all users to access common on-line,
real-time information. When the system is fully installed, it will
result in financial, operational, and customer service
improvements. These improvements should include enhanced system
support for managing sales orders, production planning and
scheduling, materials planning, lot traceability, and distribution
requirements planning. Holopack also anticipates using the system
to facilitate an enhanced environment. "SAP will provide Holopack
the needed platform to maximize our manufacturing and product
development processes,� said Mohammad Sageghi, VP for Holopack.
�Answerthink is assisting us to raise the bar to even greater
heights while exceeding our expectations in both customer service
and implementation.� According to Answerthink SAP Solutions Group
Managing Director John McGrath, "We're delighted to be working with
Holopack. We believe that our EzPharma solution will provide
superior value to a growing, innovative customer, like Holopack.
Many small and midsize companies are coming to the conclusion that
they can take on world-class software from SAP if a preconfigured,
industry-based approach is used." Answerthink is a strategic
business and technology consulting firm that enables companies to
achieve world-class business performance. SAP All-in-One solutions
are industry-specific software, implementation, and training
solutions developed by SAP partners using SAP applications.
EzPharma is an industry-specific offering from Answerthink based on
best practices from SAP and customized for growing companies in
pharmaceutical manufacturing industries. It is part of
Answerthink�s EzLifeSciences family of preconfigured solutions that
are designed specifically to help life sciences companies achieve
goals such as streamlined product development, manufacture
reporting automation, and regulatory compliance, and supporting
critical business processes. Holopack is one of thirteen life
sciences companies that has selected SAP, Answerthink and
EzLifeSciences within the past 12 months. About Answerthink
Answerthink, Inc. (www.answerthink.com) is a leading business and
technology consulting firm that enables companies to achieve
world-class business performance. By leveraging the comprehensive
database of The Hackett Group, Answerthink's business and
technology solutions help clients significantly improve performance
and maximize returns on technology investments. Answerthink's
capabilities include benchmarking, business transformation,
business applications, business intelligence, and offshore
application development and support. Founded in 1997, Answerthink
has offices throughout the United States and in Europe and India.
Answerthink was named the 2006 SAP SME Partner of the Year.
Copyright � 2007 Answerthink, Inc. All rights reserved.
Answerthink, EzPharma and EzLifeSciences as well as their
respective logos are trademarks or registered trademarks of
Answerthink, Inc. Copyright � 2007 SAP AG. All rights reserved.
SAP, R/3, SAP, SAP.com, xApps, xApp, SAP NetWeaver and other SAP
products and services mentioned herein as well as their respective
logos are trademarks or registered trademarks of SAP AG in Germany
and in several other countries all over the world. All other
product and service names mentioned are the trademarks of their
respective companies. Data contained in this document serves
informational purposes only. National product specifications may
vary. This press release contains "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 and involve known and unknown risks, uncertainties and
other factors that may cause Answerthink's actual results,
performance or achievements to be materially different from the
results, performance or achievements expressed or implied by the
forward-looking statements. Factors that impact such
forward-looking statements include, among others, the ability of
the products, services, or practices mentioned in this release to
deliver the desired effect, our ability to effectively integrate
acquisitions into our operations, our ability to attract additional
business, our ability to effectively market and sell our
transformation advisory product offerings and other services, the
timing of projects and the potential for contract cancellations by
our customers, changes in expectations regarding the information
technology industry, our ability to attract and retain skilled
employees, possible changes in collections of accounts receivable,
risks of competition, price and margin trends, changes in general
economic conditions and interest rates as well as other risks
detailed in the Company's Annual Report on Form 10-K for the fiscal
year ended December 29, 2006 filed with the Securities and Exchange
Commission. We undertake no obligation to update or revise publicly
any forward-looking statements, whether as a result of new
information, future events or otherwise.
Answerthink (NASDAQ:ANSR)
Historical Stock Chart
From Jul 2024 to Aug 2024
Answerthink (NASDAQ:ANSR)
Historical Stock Chart
From Aug 2023 to Aug 2024